The Grace Gawler Institute - Cancer Care Disruptors
We’re all familiar with the following industry disruptors & the benefits they bring to the public.
Airbnb, the worlds biggest rental agency, owns no property.
Uber, the largest taxi firm, owns no cars.
Facebook, the biggest media company, creates no content.
Alibaba, the most valuable retailer, carries no stock.
Disruptors are Change Agents who rock the boat, replacing old business models with more effective ones.
OUR CANCER NAVIGATION SERVICE DISRUPTS OUTDATED & FRAGMENTED ASSEMBLY LINE MEDICINE
As cancer care disruptors; our referrals & management can save or extend the lives of patients who had exhausted treatments here:
Our Global Cancer Navigation Service, disrupts traditional, fragmented, outdated models of cancer medicine & care.
These slow-to-change medical models, despite good intention & massive government investment, are unable to adequately assist all cancer patients – especially those with rare, difficult to treat or advanced cancers. When patients are told – there is nothing more we can do – that statement highlights the limitations of our medical systems.
FACT: Standards of cancer care vary globally; e.g. medicines approved in the USA may take years to be approved in Australia, NZ (or the UK). Some treatments such as PBT (Proton Beam Therapy) may never come to AU & NZ.
FACT: There is a revolution occurring – Precision Medicine – we help you access it NOW. It’s not found in most cancer hospitals here.
YOUR CANCER IS GENETICALLY UNIQUE - YOU DESERVE A PERSONALISED TREATMENT PROGRAM
Most often today, your treatment plan doesn’t have all that much to do with you specifically. It’s identical to what doctors would hand over to essentially anyone with the same condition — your neighbour, the hot dog vendor at Wrigley Field, or the prime minister of Bangladesh. GENOME MAG read more
Our Cancer Navigation Service can help you access Precision Medicine NOW – especially when your hospital can’t help anymore – We’ve always got your back:
Australia lags behind comparable countries for access to new medicines
Cancer medicine changed dramatically with the mapping of the human genome
Then came Pharmaco-genomics – these tests can measure how we metabolise medicines (and supplements). The tests showed us that unless cancer medicines were genetically targeted or personalised, they would experience a higher failure rate.
Outdated Models: The old models stratify patients into groups for the efficient distribution of medicines & treatments. (genomic tests can indicate the treatments will not work for all the group). But few hospitals use such tests; so these patients will fail treatment and then be shunted into other treatments which may also not work.
This is trial and error medicine with the patient’s life on the line. It is one size fits all medicine. And; as our doctor in the picture suggests – one size does not fit all. Innovation moves slowly in cancer medicine. Unlike small organisations like the Grace Gawler Institute, big medical systems & hospital conglomerates are not medically or scientifically agile.
Genomic Era: Consequently – the Grace Gawler Institute (GGI) Services moved into the genomic era some years ago. Today, we are able to help patients access state-of-the-art genomic diagnostic testing – this in turn identifies targeted treatments better than any previous techniques – this in turn predicts better outcomes with fewer side effects.
Global Alliance: For many decades we (GGI) have been adding innovative cancer doctors & clinics to our global alliance. Therefore; we are ideally positioned to help patients access targeted treatments based on their tumour’s genetic signature; increasing the probability of positive outcomes.
Hospitals and Precision Medicine (personalised or targeted medicine): While most bigger hospitals are still investigating & researching precision medicine; we can help our patients access precision medicine in current time – NOW